Curemark, LLC is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Curemark’s pipeline includes preclinical and clinical-stage programs for the treatment of Autism, ADHD, addiction, Schizophrenia and Parkinson’s disease.
View Top Employees from Curemark, LLC| Website | http://www.curemark.com |
| Revenue | $3 million |
| Funding | $67.6 million |
| Employees | 22 (13 on RocketReach) |
| Founded | 2006 |
| Address | 411 Theodore Fremd Ave. Suite 206 S, Rye, New York 10580, US |
| Phone | (914) 824-9700 |
| Technologies |
JavaScript,
HTML,
PHP
+12 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Business Services General, Business Services, Science and Engineering, Research & Development, Health Diagnostics, Autism, Health Care, Therapeutics |
| Web Rank | 12 Million |
| Keywords | Curemark Llc, Curemark |
| Competitors | CymaBay Therapeutics, Knopp Neurosciences, NGM Biopharmaceuticals, PhaseBio Pharmaceuticals, Inc., 上海泽生科技开发股份有限公司 |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Curemark, LLC employee's phone or email?
Curemark, LLC Questions
The Curemark, LLC annual revenue was $3 million in 2024.
Matthew Heil is the Chief Scientific Officer of Curemark, LLC.
13 people are employed at Curemark, LLC.
Curemark, LLC is based in Rye, New York.
The NAICS codes for Curemark, LLC are [32541, 3254, 325, 32].
The SIC codes for Curemark, LLC are [283, 28].
Top Curemark, LLC Employees
-
31
-
21
-
25+
-
55
-
25
-
22
-
23
-
ViewKristin Walsh
Director of Clincal Operations at Curemark, LLC
New York, New York, United States22
Related Companies
